Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Collingridge

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
The Lancet. Oncology|July 7, 2007
Breast cancer: a call for papersDavid Collingridge
The Lancet. Oncology|July 30, 2010
Expression of concern--validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trialDavid Collingridge
The Lancet. Oncology|June 12, 2022
2022 ASCO Annual MeetingDavid Collingridge
The Lancet. Oncology|December 17, 2008
World Cancer Declaration: a need for partnershipDavid Collingridge
The Lancet. Oncology|September 18, 2022
ESMO Congress 2022David Collingridge
The Lancet. Oncology|February 2, 2015
19th Society for Neuro-Oncology Annual MeetingDavid Collingridge
The Lancet. Oncology|June 9, 2020
2020 ASCO Virtual Annual MeetingDavid Collingridge
The Lancet. Oncology|October 4, 2017
Cancer in Peru: a detailed examinationCassandra Coburn, David Collingridge
The Lancet. Oncology|February 3, 2007
Practice-changing research: a call for papersDavid Collingridge, Richard Turner
The Lancet. Oncology|October 4, 2015
Primary care and cancer: integration is keyCassandra Coburn, David Collingridge
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
The Lancet. Oncology|July 7, 2007
Breast cancer: a call for papersDavid Collingridge
The Lancet. Oncology|July 30, 2010
Expression of concern--validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trialDavid Collingridge
The Lancet. Oncology|June 12, 2022
2022 ASCO Annual MeetingDavid Collingridge
The Lancet. Oncology|December 17, 2008
World Cancer Declaration: a need for partnershipDavid Collingridge
The Lancet. Oncology|September 18, 2022
ESMO Congress 2022David Collingridge
The Lancet. Oncology|February 2, 2015
19th Society for Neuro-Oncology Annual MeetingDavid Collingridge
The Lancet. Oncology|June 9, 2020
2020 ASCO Virtual Annual MeetingDavid Collingridge
The Lancet. Oncology|October 4, 2017
Cancer in Peru: a detailed examinationCassandra Coburn, David Collingridge
The Lancet. Oncology|February 3, 2007
Practice-changing research: a call for papersDavid Collingridge, Richard Turner
The Lancet. Oncology|October 4, 2015
Primary care and cancer: integration is keyCassandra Coburn, David Collingridge
Pageof 7